Questions posed by iPrEx

The success of the iPrEx study has raised as many urgent questions as it has answered. This became clear after the trial results were announced, when the findings were discussed by Anthony Fauci, head of the US National Institute of Allergies and Infectious Diseases (NIAID), who were the biggest funders of the trial, and Bob Grant, the iPrEx study’s Principal Investigator.

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap